| Bria Deshea Barjuca, APRN-CNP | |
|
4450 Eastgate Blvd Ste 232, Cincinnati, OH 45245-1788 | |
| (513) 770-4212 | |
| Not Available |
| Full Name | Bria Deshea Barjuca |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 4450 Eastgate Blvd Ste 232, Cincinnati, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023623808 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | APRN.CNP.0027517 (Ohio) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | APRN.CNP.0027517 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Dermatology Group Inc | 6406740141 | 19 |
News Archive
In Maine, insurance regulators say measures aimed at expanding health coverage to more people in that state should wait for final action in Congress, The Associated Press/WBZ reports. A Maine report "released last week, stems from a 2009 law that asks the superintendent to review ways to improve the availability and affordability of Maine's individual health insurance market." In the report, the authors write that Maine's options to expand access and make coverage more affordable will depend on what Congress does.
The University of Texas MD Anderson Cancer Center and RaySearch Laboratories today announced a strategic alliance with the aim of enhancing cancer radiation therapy through several initiatives, including more precisely targeting of tumors and improving upon, and making more available, an existing radiation therapy called adaptive radiation therapy, currently only used at highly specialized care centers.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that Jiangsu Yanshen Biological Technology Stock Co., Ltd. has received disciplinary notice from China's State Food and Drug Administration regarding its production of substandard quality human use rabies vaccine.
A unique device developed to make brain surgery easier and less traumatic has been successfully used on a patient who was pregnant and suffering from a potentially life-threatening brain cyst. The device, called a "Brain Port," was pioneered by renowned neurosurgeon Amin Kassam, MD, Medical Director of the Neuroscience Institute at Saint John's Health Center.
The Substance Abuse and Mental Health Services Administration has developed a series of Metro Briefs providing detailed statistical snapshots of drug- related visits to hospital emergency departments occurring in 11 metropolitan areas across the nation.
› Verified 4 days ago
| Entity Name | The Dermatology Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780617860 PECOS PAC ID: 6406740141 Enrollment ID: O20040212000202 |
News Archive
In Maine, insurance regulators say measures aimed at expanding health coverage to more people in that state should wait for final action in Congress, The Associated Press/WBZ reports. A Maine report "released last week, stems from a 2009 law that asks the superintendent to review ways to improve the availability and affordability of Maine's individual health insurance market." In the report, the authors write that Maine's options to expand access and make coverage more affordable will depend on what Congress does.
The University of Texas MD Anderson Cancer Center and RaySearch Laboratories today announced a strategic alliance with the aim of enhancing cancer radiation therapy through several initiatives, including more precisely targeting of tumors and improving upon, and making more available, an existing radiation therapy called adaptive radiation therapy, currently only used at highly specialized care centers.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that Jiangsu Yanshen Biological Technology Stock Co., Ltd. has received disciplinary notice from China's State Food and Drug Administration regarding its production of substandard quality human use rabies vaccine.
A unique device developed to make brain surgery easier and less traumatic has been successfully used on a patient who was pregnant and suffering from a potentially life-threatening brain cyst. The device, called a "Brain Port," was pioneered by renowned neurosurgeon Amin Kassam, MD, Medical Director of the Neuroscience Institute at Saint John's Health Center.
The Substance Abuse and Mental Health Services Administration has developed a series of Metro Briefs providing detailed statistical snapshots of drug- related visits to hospital emergency departments occurring in 11 metropolitan areas across the nation.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bria Deshea Barjuca, APRN-CNP 716 Sycamore St Unit 711, Cincinnati, OH 45202-2197 Ph: (859) 707-0335 | Bria Deshea Barjuca, APRN-CNP 4450 Eastgate Blvd Ste 232, Cincinnati, OH 45245-1788 Ph: (513) 770-4212 |
News Archive
In Maine, insurance regulators say measures aimed at expanding health coverage to more people in that state should wait for final action in Congress, The Associated Press/WBZ reports. A Maine report "released last week, stems from a 2009 law that asks the superintendent to review ways to improve the availability and affordability of Maine's individual health insurance market." In the report, the authors write that Maine's options to expand access and make coverage more affordable will depend on what Congress does.
The University of Texas MD Anderson Cancer Center and RaySearch Laboratories today announced a strategic alliance with the aim of enhancing cancer radiation therapy through several initiatives, including more precisely targeting of tumors and improving upon, and making more available, an existing radiation therapy called adaptive radiation therapy, currently only used at highly specialized care centers.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that Jiangsu Yanshen Biological Technology Stock Co., Ltd. has received disciplinary notice from China's State Food and Drug Administration regarding its production of substandard quality human use rabies vaccine.
A unique device developed to make brain surgery easier and less traumatic has been successfully used on a patient who was pregnant and suffering from a potentially life-threatening brain cyst. The device, called a "Brain Port," was pioneered by renowned neurosurgeon Amin Kassam, MD, Medical Director of the Neuroscience Institute at Saint John's Health Center.
The Substance Abuse and Mental Health Services Administration has developed a series of Metro Briefs providing detailed statistical snapshots of drug- related visits to hospital emergency departments occurring in 11 metropolitan areas across the nation.
› Verified 4 days ago